Processes for preparing clarithromycin polymorphs

Details for Australian Patent Application No. 2001222619 (hide)

International Classifications

Event Publications

28 April 2005 Application Accepted

Published as AU-B-2001222619

14 July 2005 Corrigenda

Applications Accepted - Name Index Under the name Teva Pharmaceutical Corrigenda Industries Ltd., Application No. 2001222619, under INID (72) correct the inventors to read Schwartz, Edi, Avrutov, Ilya, Lifshitz, Igor and Masarwa, Basem.

18 August 2005 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 27 Jul 2005. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

25 August 2005 Standard Patent Sealed

12 January 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 27 Jul 2005

10 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.